Shan Tao, Zhu Yahui, Fan Haozhi, Liu Zeye, Xie Jing, Li Mao, Jing Shenqi
Department of Outpatient, The First Affiliated Hospital with Nanjing Medical University, Nanjing, China.
School of Information Management, Nanjing University, Nanjing, China.
Front Neurol. 2024 Aug 15;15:1418926. doi: 10.3389/fneur.2024.1418926. eCollection 2024.
Epilepsy is a non-communicable chronic brain disease that affects all age groups. There are approximately 50 million epilepsy patients worldwide, which is one of the most common neurological disorder. This study reports the time trends in the burden of epilepsy from 1999 to 2019.
We evaluated the disease burden and its temporal trends of epilepsy using the prevalence and years lived with disability (YLDs), which was estimated based on the Global Burden of Disease (GBD) 2019 study. The age-period-cohort (APC) model was used to estimate the temporal trends of the epilepsy prevalence and YLDs rates, and to analyze the relative risks of age, periods and queues (age/period/queue effects).
In the past 30 years, the global age-standardized prevalence rate and age-standardized rate has increased by 29.61% and 27.02%, respectively. Globally, the APC model estimated the net drift of prevalence and YLDs were 0.88% (95% CI: 0.83-0.93) and 0.80% (95% CI: 0.75-0.85) per year. Among 204 countries and territories, the YLDs in 146 and prevalence 164 showed an increasing trend. And the risk of YLDs and prevalence increases with age, with the lowest risk among 0-4 years old and the highest risk among 75-79 years old. Unfavorable increasing period and cohort risks of YLDs and prevalence were observed.
Over the past 30 years, the YLDs and prevalence of epilepsy have gradually increased globally and unfavorable increasing period and cohort risks were observed. Emphasizing epilepsy prevention, strengthening epilepsy health education, optimizing older adults epilepsy diagnosis and treatment plans, and actively promoting epilepsy diagnosis and treatment plans can effectively reduce new cases of epilepsy and related disabilities.
癫痫是一种影响所有年龄组的非传染性慢性脑病。全球约有5000万癫痫患者,是最常见的神经系统疾病之一。本研究报告了1999年至2019年癫痫负担的时间趋势。
我们使用患病率和伤残调整生命年(YLDs)评估癫痫的疾病负担及其时间趋势,这是根据《2019年全球疾病负担》(GBD)研究估计的。年龄 - 时期 - 队列(APC)模型用于估计癫痫患病率和YLDs率随时间的变化趋势,并分析年龄、时期和队列的相对风险(年龄/时期/队列效应)。
在过去30年中,全球年龄标准化患病率和年龄标准化率分别上升了29.61%和27.02%。在全球范围内,APC模型估计患病率和YLDs的年净变化率分别为0.88%(95%CI:0.83 - 0.93)和0.80%(95%CI:0.75 - 0.85)。在204个国家和地区中,146个地区的YLDs和164个地区的患病率呈上升趋势。YLDs和患病率的风险随年龄增长而增加,0 - 4岁风险最低,75 - 79岁风险最高。观察到YLDs和患病率存在不利的时期和队列增加风险。
在过去30年中,全球癫痫的YLDs和患病率逐渐上升,并观察到不利的时期和队列增加风险。强调癫痫预防、加强癫痫健康教育、优化老年人癫痫诊断和治疗方案,积极推广癫痫诊断和治疗方案,可以有效减少癫痫新发病例和相关残疾。